Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • COPYRIGHT—S.D.N.Y.: AI platform sellers lose copyright suit; royalty dispute heads to arbitration
    • COPYRIGHT NEWS: Former Eminem employee pleads guilty to selling unreleased music
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COPYRIGHT—9th Cir.: Jury verdict in copyright suit over AppleTV Servant series upheld
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PATENT NEWS: XOLAIR makers sue Kashiv, Amneal over proposed omalizumab biosimilar
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • TECHNOLOGY/INTERNET—N.D. Tex.: Ashley St. Clair’s motion to dismiss breach of contract countersuit by xAI denied
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • TRADE SECRETS—S.D. Cal.: Mortgage lender’s trade secret claims against former manager and coaching company proceed
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    IP Law Daily, PATENT NEWS: XOLAIR makers sue Kashiv, Amneal over proposed omalizumab biosimilar, (Oct 23, 2026)

    Law Firms Mentioned:McCarter & English, LLP
    Organizations Mentioned:Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, Inc. | Genentech, Inc. | Kashiv Biosciences, LLC | Novartis Pharmaceuticals Corp.

    By Saurabh Kashyap, B.A., M.A., LL.B., LL.M.

    Genentech and Novartis alleged that Kashiv’s BLA for ADL-018 would infringe nine patents covering the manufacture and use of XOLAIR and related biologic technology.

    Genentech, Inc. and Novartis Pharmaceuticals Corp. have sued Kashiv BioSciences ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use